CAMP4 Accounts Payable vs Other Stockholder Equity Analysis
| CAMP Stock | USD 4.79 0.10 2.13% |
CAMP4 THERAPEUTICS financial indicator trend analysis is way more than just evaluating CAMP4 THERAPEUTICS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CAMP4 THERAPEUTICS is a good investment. Please check the relationship between CAMP4 THERAPEUTICS Accounts Payable and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Accounts Payable vs Other Stockholder Equity
Accounts Payable vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CAMP4 THERAPEUTICS Accounts Payable account and Other Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between CAMP4 THERAPEUTICS's Accounts Payable and Other Stockholder Equity is 0.52. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of CAMP4 THERAPEUTICS PORATION, assuming nothing else is changed. The correlation between historical values of CAMP4 THERAPEUTICS's Accounts Payable and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of CAMP4 THERAPEUTICS PORATION are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Accounts Payable i.e., CAMP4 THERAPEUTICS's Accounts Payable and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.52 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Accounts Payable
An accounting item on the balance sheet that represents CAMP4 THERAPEUTICS obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of CAMP4 THERAPEUTICS are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Other Stockholder Equity
Most indicators from CAMP4 THERAPEUTICS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, CAMP4 THERAPEUTICS's Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Enterprise Value Over EBITDA is likely to grow to 535.90, while Issuance Of Capital Stock is likely to drop 0.00.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 15.3M | 6.3M | 4.7M | 8.3M | Depreciation And Amortization | 22.8M | 21.8M | 19.6M | 17.8M |
CAMP4 THERAPEUTICS fundamental ratios Correlations
Click cells to compare fundamentals
CAMP4 THERAPEUTICS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with CAMP4 THERAPEUTICS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.Moving against CAMP4 Stock
| 0.67 | VINC | Vincerx Pharma | PairCorr |
| 0.42 | DTIL | Precision BioSciences | PairCorr |
| 0.32 | DRMA | Dermata Therapeutics | PairCorr |
| 0.31 | VCNX | Vaccinex | PairCorr |
| 0.31 | DRTS | Alpha Tau Medical | PairCorr |
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.